Evidence map›Paper›PMID 37674880›Full record

ArticleACG case reports journal2023

Gastric Myeloid Sarcoma.

Abdullah S Shaikh, Emmanuel Almanza Huante, Mehran Taherian, Andres E Quesada, Elias J Jabbour, Selvi Thirumurthi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in ACG case reports journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Rare Presentation of Gastric Myeloid Sarcoma.ACG case reports journal · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Abdullah S ShaikhDepartment of Gastroenterology, Hepatology, and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID https://orcid.org/0000-0002-3580-7002
Emmanuel Almanza HuanteDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
Mehran TaherianDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Andres E QuesadaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Elias J JabbourDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
Selvi ThirumurthiDepartment of Gastroenterology, Hepatology, and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most gastric cancers are adenocarcinomas, but other malignancies can arise in the stomach. Patients with leukemia may develop myeloid sarcoma (MS) in the gastrointestinal tract. Our patient was a 68-year-old woman who was initially diagnosed with acute myeloid leukemia and underwent a matched unrelated stem cell transplantation. She was in remission for 10 years before developing a rare case of gastric MS without acute myeloid leukemia. She had partial response to chemotherapy but ultimately died because of infection. Gastric MS has an incidence of less than 1%. Gastrointestinal involvement usually involves the small intestine and rarely the stomach.

Indexed as

acute myeloid leukemiaanemiaclonal cytopenia of undetermined significancegastric massimmunohistochemistrymyeloid sarcomastomach

Identifiers

PMID37674880
PMCPMC10479346
OpenAlexW4386453187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.